2025-03-08 HaiPress
On March 8, 2025, AB DAO announced that $AB has officially been listed on Hotcoin (hotcoin.com) at 18:00 (UTC+8), further expanding its global trading network and driving AB’s adoption in the Web3 ecosystem. Additionally, $AB is set to be listed on four more major exchanges: Gate (gate.io), BitMart (bitmart.com), Lbank (lbank.com), and Biconomy (biconomy.com), significantly enhancing AB’s global liquidity and ecosystem reach.
AB Trading Details
Trading Pair: AB/USDT
Deposit Opening: March 7, 2025, 12:00 (UTC+8)
Trading Opening: March 8, 2025, 18:00 (UTC+8)
Hotcoin Official Announcement: https://www.hotcoin.com/zh_CN/support/article/?id=25704168485425152&code=25704168485163008&catalogCode=19112597563772928
AB DAO Ecosystem Continues to Expand
With the Hotcoin listing, users can now trade $AB on the following exchanges:
Bitget (bitget.com)
HTX (htx.com)
MEXC (mexc.com)
BingX (bingx.com)
Hotcoin (hotcoin.com)
4E (eeee.com)
Gate (gate.io) (Coming Soon)
BitMart (bitmart.com) (Coming Soon)
Lbank (lbank.com) (Coming Soon)
Biconomy (biconomy.com) (Coming Soon)
The listing of $AB on Hotcoin marks another major step in AB DAO’s global expansion strategy. In the coming months, AB will continue listing on more exchanges, expanding its ecosystem use cases and accelerating worldwide adoption.
AB DAO’s Goal: 100 Million $AB Holders
Now is the time to join the movement—unite, strengthen the community, and drive the expansion of the AB ecosystem. The mission is clear: onboard tens of millions of users and build a decentralized future together.
Stay Updated with AB DAO
Official Website: https://ab.org
Telegram Global Community: https://t.me/Newtonproject
Telegram Chinese Community: http://t.me/ABgonglian
Telegram English Channel: https://t.me/AB202528
X (Twitter): https://x.com/ABDAO_Global
Discord: https://discord.gg/BSbgK6J
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright2009-2020Fresh life